Oncology The future of oncology is adaptive: What ESMO 2026 revealed ... Across tumours, three developments repeatedly surfaced throughout the congress, each reflecting a notable transition in how cancer is being managed.
Partner Content Partner Content Four weeks until Adaptive Designs in Clinical Trials Confere... Four weeks until SMi’s 11th Annual Conference
Partner Content Partner Content Pfizer’s vice president & Head of Early Clinical Develop... Adaptive Designs in Clinical Trials 2019
Partner Content Partner Content SMi’s Adaptive Design in Clinical Trials - 4 days to go SMi’s Adaptive Design in Clinical Trials
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.